XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection

Abstract The newly identified XBB.1.16‐containing sublineages, including XBB.1.5, have become the prevailing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant in circulation. Unlike previous Omicron XBB variants (e.g., XBB.1.5 and XBB.1.9) harboring the F486P substitution, XBB.1.1...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dandan Peng, Cai He, Zimin Chen, Hong Lei, Xiya Huang, Chunjun Ye, Binhan Wang, Ying Hao, Xinyi Du, Shuaiyao Lu, Hongbo Hu, Wei Cheng, Haohao Dong, Jian Lei, Xikun Zhou, Xiangrong Song, Guangwen Lu, Xiawei Wei
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2024-09-01
Series:	MedComm
Assuntos:	heterologous booster recombinant RBD‐HR protein XBB.1.16 variant
Acceso en liña:	https://doi.org/10.1002/mco2.687
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!